As we age, many of us experience increased inflammation that can affect our muscles and joints. This study is investigating whether Maolactin can help:

• Reduce chronic inflammation in the body
• Improve joint and muscle comfort
• Enhance mobility and reduce stiffness
• Decrease muscle fatigue during activity

Previous research on similar products has shown promising anti-inflammatory and immune support properties. Lowering inflammation is a key factor often associated with a long and healthy life. This study aims to determine if Maolactin could offer a natural approach to lowering inflammation and improving quality of life.

Participants on this study will take the study product daily for 8 weeks. We are recruiting on a rolling basis which means that your individual start date is flexible and can be at a time most convenient for you.

 Please see below for more information. You can also register your interest using the form at the bottom of this page.

Maolactin is a natural, milk-based protein supplement. The supplement contains a blend of functional proteins formulated to lower inflammation and enhance muscle recovery. This innovative product is aimed at reducing inflammation which leads to improved mobility and reduced discomfort.

The product will be supplied in capsule form, and participants will be asked to take 2 capsules daily for 8 weeks.

As this study is placebo-controlled, you may or may not be allocated the active product. In this study, there is 1 active group and 1 placebo group, so you will have a 50% chance of receiving the active product.

Using a placebo helps us to be confident that any effects we measure in the active group really are due to the active ingredient and not due to the body’s own reaction to a perceived treatment.

As we age, we tend to have an increase in inflammation production both at rest and during physical activity that can affect our muscles, joints and overall health negatively. Due to the potential issues that can arise with both age and exercise, supplement options need to be available to help decrease skeletal muscle inflammation as well as everyday muscle and joint pains.

Those who suffer from inflammation and/or muscle and joint pain turn to aids to assist and improve their daily activity. These can include prescription and over the counter medications or herbal supplements. Whilst some of these may be effective in the short term, there can be associated side effects, some being ineffective, poorly tolerated, and/or create dependency.  Therefore, it is important to develop aids that have little to no side effects while also addressing the cause of the problem.

Most of the study requirements can be completed at home; however, you will be required to attend either the ACL Norwest or Darlinghurst pathology clinic twice during the study.

During the study, you will be asked to:

• Take the study product daily (in capsule form) for 8 weeks.
• Attend a pathology clinic 2 times, to have a blood test.
• Complete a series of short questionnaires at 3 timepoints throughout the study.

To make the timings of these visits as convenient as possible for you, we are recruiting on a rolling basis. This means that your individual start date is flexible.

Please note: This page is a summary of the study outline and participant requirements. A full Participant Information Sheet with detailed information will be provided to you before you are asked to give your consent to participate.

We value your time and commitment to this research. Upon completion of the study requirements, you will be eligible for a $275 reimbursement for your time and travel expenses. The payment will be made via direct deposit to your nominated bank account once all study requirements have been met. You can also elect to be reimbursed with vouchers.

Pro rata payments are also available in the case of early withdrawal. 

If you are interested in participating, we’d love to hear from you. Please register your interest by answering the questionnaire and completing the form on this page…we’ll then get in touch to screen you for eligibility.

This study is a remote study, meaning most of the study is completed over the phone and online. In addition, you will be required to attend either the ACL Norwest or Darlinghurst pathology clinic.

• Norwest Private Hospital – Suite G19, 11 Norbrik Drive Bella Vista
• Darlinghurst – Level 3, 393 Bourke Street Darlinghurst

The MAOJOI Study is lead by Dr David Briskey (PhD) and Dr Amanda Rao (PhD) who have extensive experience in outpatient clinical research for healthier outcomes. Our friendly team at RDC Clinical has helped thousands of Australians participate in research over the past 2 decades. 

• Adults 45 years of age or older
• Generally healthy with no uncontrolled or serious illnesses
• BMI 25-35 kg/m2 (you can check this on the BMI calculator on this page)
• Feel pain or discomfort in joints or muscles for at least 3 months
• Inflammation (CRP) equal to or greater than 2.0 mg/L (we will test for this)
• Able to provide informed consent
• Able to commit to completing the study requirements

Please register your interest by answering the questionnaire and completing the form on this page… we’ll then get in touch to screen you for suitability.

Please note: This page is a summary of the study outline and participant requirements. A full Participant Information Sheet with more detailed information will be provided to you before you are asked to give your consent to participate.

This RDC Clinical study has been approved by the Bellberry Human Research Ethics Committee under Approval Number: 2024-03-328. The study is also registered on the clinicaltrials.gov under Registration Number: NCT06444763.

Trained trial coordinators will supervise your progress throughout the study. Your results will be made available to you at the conclusion of the study. Any of your personal information collected during the study will be kept in the strictest confidence.